tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gregory Renza, 135 are a BUY (79.88%), 34 are a HOLD (20.12%).
Analyst Gregory Renza works at RBC with a stock forecast success ratio of 34.17% fulfilled within 113.39 days on average.
Gregory Renza’s has documented 332 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRMD, CorMedix at 13-Mar-2024.
Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $111 was fulfilled within 1 day with a profit of $15.2 (15.87%) receiving and performance score of 158.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$7.2 (40.45%)
29
25 days ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$12.2 (68.54%)
40
1 months 6 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$21.2 (119.10%)
40
1 months 22 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$15.2 (85.39%)
33
1 months 22 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Buy
36
$18.2 (102.25%)
1 months 22 days ago
0/1 (0%)
$12.25 (51.58%)
Which stock is Gregory Renza is most bullish on?
Which stock is Gregory Renza is most reserved on?
What Year was the first public recommendation made by Gregory Renza?
